Allogene Therapeutics, Inc. (ALLO) Earnings
NASDAQ·Healthcare·Biotechnology
$2.05
+7.37%
Mkt Cap $463.35M
EPS — Estimate vs Actual
Mkt Cap
$463.35M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.77
NASDAQ·Healthcare·Biotechnology
$2.05
+7.37%
Mkt Cap $463.35M
Mkt Cap
$463.35M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.77